Daniel Gruber, MD
Urogynecology and Reconstructive Pelvic Surgery · Bethesda, MDNPI 1841225133
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $61,800 of the $90,837 with a category attached, or 68.0%. AbbVie accounts for 78.2% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $24,873, more than ten times the $481 reported in 2019.
Across 212 payments — averaging $428.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$71K
- Pacira Pharmaceuticals Incorporated$8K
- Caldera Medical, Inc$7K
- Axonics, Inc.$2K
- Boston Scientific$2K
- Coloplast$1K
- plus $572 from 9 others
What the payments were for
- Consulting fees$11,47513%
- Speaking & faculty fees$61,80068%
- Travel & lodging$10,17111%
- Food & beverage$7,3368%
- Gifts$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 121 | $71,009 |
| Pacira Pharmaceuticals Incorporated | 19 | $7,662 |
| Caldera Medical, Inc | 14 | $6,970 |
| Axonics, Inc. | 16 | $1,741 |
| Boston Scientific | 13 | $1,506 |
| Coloplast | 13 | $1,377 |
| Renovia Inc | 1 | $144 |
| Coopersurgical, Inc. | 1 | $105 |
| Integra Lifesciences Corporation | 3 | $85 |
| Sumitomo Pharma America, Inc. | 5 | $81 |
| Medtronic | 1 | $51 |
| Bluewind Medical | 2 | $37 |
| Merck | 1 | $26 |
| Abbott | 1 | $22 |
| Valencia Technologies Corporation | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$69,182
- EXPAREL$7,255
- Desara$6,067
- ALTIS$1,218
- Axonics r-SNM System$1,026
- Bulkamid$1,026
- UPSYLON$434
- GENERAL - THERAPIES$425
- Axonics$251
- Leva Pelvic Floor Trainer$144
- LithoVue$121
- SUPRIS$114
- Solyx SIS System$109
- Advantage System$108
- WALLACH Cryosurgical Equipment$105
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 79 | $48,818 |
| Estradiol | 146 | $9,585 |
| Methenamine Hippurate | 14 | $1,816 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $207 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $108 |
| Oxycodone Hcl | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Bethesda
- Heather BarbierBethesda$10K
- Christine VaccaroBethesda$7K
- Eva WelchBethesda$4K
- Mava Robinson-WaltonSilver Spring$257K
- Anita Pillai AllenSilver Spring$38K
- Aisha TaylorHanover$29K
- Robert GutmanBaltimore$28K
- Yong ZhengBowie$14K
- Kay HoskeyAnnapolis$9K
- Richard EllerkmannLutherville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.